August 30 (SeeNews) - Croatian pharmaceuticals producer Jadran Galenski Laboratorij (JGL) turned to a consolidated net profit of 26 million kuna ($3.9 million/3.5 million euro) in the first half of 2019, from a 19 million kuna loss in the like period of 2018, as revenues rose faster than expenditures, it said.
Jun 10, 2026
BucharestJun 30, 2026Marrakech
